InvestSMART

MedAdvisor Limited (ASX:MDR)

ALERT: Price-sensitive ASX Announcement for MDR
Current share price for MDR : $0.022 -0.003 (-12%)+
Announcement
Release
7 Nov 2025 8:13AM
Price at Release
$0.025
Full Release
download
Summary
MedAdvisor Limited, a leader in pharmacy-driven patient engagement solutions, has announced the appointment of John Ciccio as its new CEO and Managing Director, effective 7 November 2025. Ciccio, who has significant experience in healthcare technology and previously led Adheris Health, brings deep expertise in commercial strategy and operational leadership. He succeeds Rick Ratliff, who will remain in an advisory role to ensure a smooth transition. Under Ratliff's tenure, MedAdvisor achieved key milestones, including the divestment of its ANZ business and the elimination of all debt. The company is poised for future growth with the upcoming launch of its next-generation engagement platform. Ciccio's employment terms include a starting annual salary of USD325,000, increasing upon achieving specific performance targets, and he is subject to post-employment restraint clauses.
Key Points
  • MedAdvisor Limited announces John Ciccio as the new CEO and Managing Director.
  • Rick Ratliff, the outgoing CEO, will assist in the transition.
  • John Ciccio brings 12 years of experience from Adheris Health, which MedAdvisor acquired in 2020.
  • Under Rick Ratliff's leadership, MedAdvisor divested the ANZ business and eliminated debt.
  • The company is launching a new engagement platform following Transformation 360.
  • John Ciccio's appointment includes a remuneration of USD325,000, increasing to USD425,000 based on performance.
  • Ciccio's contract includes a 6-month notice period and post-employment non-compete clauses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.